The 50th Annual General Meeting of Shareholders Other Matters Subject to the Electronic Provision Measures9/1 8:00TDnetPDF(548KB)
Consolidated Financial Results for the Fiscal Year Ended June 30, 2026 (Under Japanese GAAP)8/14 15:30TDnetPDF(583KB)
Regarding the Execution of an Exclusive Distribution Agreement in the Japanese Market for an Intrasaccular Occlusion Device8/14 15:30TDnetPDF(190KB)
Notice concerning Upward Revision of the Numerical Targets of the Medium-Term Management Plan ‘Building the Future 2030’ and the Long-Term Vision8/14 15:30TDnetPDF(206KB)
Consolidated Financial Results for the Nine Months Ended March 31, 2026 (Under Japanese GAAP)5/15 15:30TDnetPDF(395KB)
Notice Regarding Conclusion of an Exclusive Distribution Agreement for Embolization Agents in the Japanese Market4/9 15:30TDnetPDF(183KB)
Notice Regarding Revision of Forecast for Dividends due to the Payment of a 50th Anniversary Commemorative Dividend and an Increase in Ordinary Divide2/13 15:30TDnetPDF(117KB)
Notice Regarding Revision of Full-Year Consolidated Financial Results Forecast for the Fiscal Year Ending June 30, 2026[Supplementary Materials]2/13 15:30TDnetPDF(1MB)
Notice Regarding Revision (Upward Revision) of Full-Year Consolidated Financial Results Forecast for the Fiscal Year Ending June 30, 20262/13 15:30TDnetPDF(126KB)